IL-1 genes in myasthenia gravis: IL-1A-889 polymorphism associated with sex and age of disease onset

Journal of Neuroimmunology

Volumn 122, Issue 1-2, 2002, Pages 94-99

  Sciacca, Francesca L ^a   Ferri, Cinzia ^b   Veglia, Fabrizio ^c   Andreetta, Francesca ^a   Mantegazza, Renato ^a   Cornelio, Ferdinando ^a   Franciotta, Diego ^d   Piccolo, Giovanni ^d   Cosi, Vittorio ^d   Batocchi, Anna P ^e   Evoli, Amelia ^e   Grimaldi, Luigi M E ^b,f  

^a National Neurological Institute   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c ISI FOUNDATION   (Italy)

^d C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^e CATHOLIC UNIVERSITY   (Italy)

^f AUSL2 ^*  (Italy)

Author keywords

Age of onset; Interleukin 1; Myasthenia gravis; Polymorphism

Indexed keywords

INTERLEUKIN 1ALPHA;

ADULT; AGED; ARTICLE; CHROMOSOME 2; CHROMOSOME 2Q; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE CLUSTER; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; IMMUNE RESPONSE GENE; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; ONSET AGE; PRIORITY JOURNAL; SEX RATIO;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-1; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; POLYMORPHISM, SINGLE NUCLEOTIDE; SEX FACTORS;

EID: 0036145445     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(01)00449-0     Document Type: Article

References (23)

1. Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis
2. Cytokine production by normal human monocytes: Inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism
3. Cytokines mediate protective stimulation of glucocorticoid during autoimmunity: Involvement of IL-1
4. Biological basis for interleukin-1 in disease
5. Association of early-onset Alzheimer's disease with an interleukin-1 alpha gene polymorphism
6. Different HLA-DQ are positively and negatively associated in Swedish patients with myasthenia gravis
7. Polymorphism in tumor necrosis factor genes associated with myasthenia gravis
8. Polymorphisms in IL-1β and IL-1 receptor antagonist genes are associated with myasthenia gravis
9. Tumour necrosis factor-alpha polymorphism and secretion in myasthenia gravis
10. A rare allele combination of the interleukin-1 gene complex is associated with high interleukin-1β plasma levels in healthy individuals
11. IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1beta genes
12. The function of tumor necrosis factor and receptors in models of multi-organ inflammation, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease
13. Myasthenia gravis
14. A multicentre follow-up study of 1152 patients with myasthenia gravis in Italy
15. Increased incidence of certain TCR and HLA genes associated with myasthenia gravis in Italians
16. Myasthenia gravis and tumor necrosis factor beta polymorphisms: Linkage disequilibrium but no association beyond HLA-B8
17. A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro
18. Studies in myasthenia gravis: Review of a twenty year experience in over 1200 patients
19. Relevance of Interleukin-1 receptor antagonist intron 2 polymorphism in Italian multiple sclerosis patients
20. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat
21. The immunogenetics of myasthenia gravis, multiple sclerosis and their animal model
22. Identification by genomic typing of non-DR3 HLA class II genes associated with myasthenia gravis
23. Cytokines and the pathogenesis of myasthenia gravis